In this three-hour virtual summit, leading experts share the latest developments in patient-level data sharing and data reuse. Patient data from prior clinical trials and real-world sources has the power to transform drug development. This summit offers a practical look at the solutions being developed to facilitate and promote responsible secondary data use.
- Keynote: Mark McClellan, Director, Duke-Margolis Center for Health Policy and former commissioner of the U.S. Food and Drug Administration
- Regulatory landscape panel: A global perspective on using diverse data types and sources in regulatory submissions
- Introducing draft standards for clinical trial data contributions and for the responsible research use of secondary patient data
- Data privacy and secondary patient data use: Policies and protection methodologies